DCDevyani Chowdhury

Devyani Chowdhury

*This is an algorithmically generated author record based on publicly available information.

Devyani Chowdhury has a total of 216 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnosis and management of very rare primary arrhythmia syndromes in children and adults: a Clinical Consensus Statement of the European Heart Rhythm Association of the ESC and the Association of Cardiovascular Nursing & Allied Professions of the ESC, endorsed by the Association for European Paediatric and Congenital Cardiology

    by Georgia Sarquella-Brugada, Andrea Mazzanti, Anwar Baban, Oscar Campuzano, Giulio Conte, Lia Crotti, Michael Ackerman, Elijah Behr, Nico Blom, Devyani Chowdhury, et al.

    Very rare and ultra-rare primary inherited arrhythmia syndromes (IAS) represent a heterogeneous group of disorders associated with a significant risk of sudden cardiac death, often manifesting from foetal life to early adulthood. Current guidelines primarily address more common IAS and provide limited, non-specific recommendations for these rare entities, particularly in paediatric populations. This European Heart Rhythm Association Clinical Consensus Statement, developed in collaboration with the Association of Cardiovascular Nursing and Allied Professions and endorsed by the Association for European Paediatric and Congenital Cardiology, integrates available evidence with expert opinion. Recommendations were formulated through structured discussion and voting, following ESC consensus methodology, with a focus on clinically actionable gene-disease associations. The document provides a comprehensive framework for the diagnosis and management of very rare IAS, including calmodulinopathies, Andersen–Tawil syndrome, Timothy syndrome, TRDN-related disease, calcium release deficiency syndrome, and other atypical channelopathies. It highlights age-specific clinical presentations, the importance of genetic testing, and tailored therapeutic strategies, including pharmacological treatments, left cardiac sympathetic denervation, and selective use of implantable cardioverter-defibrillators. Special attention is given to paediatric considerations, foetal diagnosis, and the role of multidisciplinary care. The document also addresses arrhythmic risk in metabolic and cardiomyopathic conditions, as well as the importance of molecular autopsy and family screening in sudden unexplained death. This consensus document fills a critical gap by providing expert-driven, pragmatic guidance for the management of very rare IAS across the lifespan. It underscores the need for specialized care, international collaboration, and prospective registries to improve evidence generation, risk stratification, and patient outcomes in this vulnerable population.


  • Open Access

    Prediction of low birth weight from fetal ultrasound and clinical characteristics: a comparative study between a low- and middle-income and a high-income country

    by Sergio Sanchez-Martinez, Pablo Miki Marti-Castellote, Zahra Hoodbhoy, Gabriel Bernardino, Josa Prats-Valero, Ainhoa M. Aguado, Lea Testa, Gemma Piella, Francesca Crovetto, Corey Snyder, et al.

    Introduction: Adverse perinatal outcomes (APO) pose a significant global challenge, particularly in low- and middle-income countries (LMICs). This study aims to analyse two cohorts of high-risk pregnant women for APO to comprehend risk factors and improve prediction accuracy. Methods: We considered an LMIC and a high-income country (HIC) population to derive XGBoost classifiers to predict low birth weight (LBW) from a comprehensive set of maternal and fetal characteristics including socio-demographic, past and current pregnancy information, fetal biometry and fetoplacental Doppler measurements. Data were sourced from the FeDoC (Fetal Doppler Collaborative) study (Pakistan, LMIC) and theIMPACT (Improving Mothers for a Better PrenAtal Care Trial) study (Spain, HIC), and included 520 and 746 pregnancies assessed from 28 weeks gestation, respectively. The models were trained on varying subsets of the mentioned characteristics to evaluate their contribution in predicting LBW cases. For external validation, and to highlight potential differential risk factors for LBW, we investigated the generalisation of these models across cohorts. Models’ performance was evaluated through the area under the curve (AUC), and their interpretability was assessed using SHapley Additive exPlanations. Results: In FeDoC, Doppler variables demonstrated the highest value at predicting LBW compared with biometry and maternal clinical data (AUCDoppler, 0.67; AUCClinical, 0.65; AUCBiometry, 0.63), and its combination with maternal clinical data yielded the best prediction (AUCClinical+Doppler, 0.71). In IMPACT, fetal biometry emerged as the most predictive set (AUCBiometry, 0.75; AUCDoppler, 0.70; AUCClinical, 0.69) and its combination with Doppler and maternal clinical data achieved the highest accuracy (AUCClinical+Biometry+Doppler, 0.81). External validation consistently indicated that biometry combined with Doppler data yielded the best prediction. Conclusions: Our findings provide new insights into the predictive role of different clinical and ultrasound descriptors in two populations at high risk for APO, highlighting that different approaches are required for different populations. However, Doppler data improves prediction capabilities in both settings, underscoring the value of standardising ultrasound data acquisition, as practiced in HIC, to enhance LBW prediction in LMIC. This alignment contributes to bridging the health equity gap.


  • Open Access

    Trends in Gaps of Care for Patients With Congenital Heart Disease: Implications for Social Determinants of Health and Child Opportunity Index

    by Abbas H. Zaidi, Adam Alberts, Devyani Chowdhury, Claude Beaty, Benjamin Brewer, Ming Hui Chen, Sarah D. de Ferranti

    Background: Lifelong continuity of care is essential for patients with congenital heart disease (CHD) to maximize health outcomes; unfortunately, gaps in care (GIC) are common. Trends in GIC and of social determinants of health factors contributing to GIC are poorly understood. Methods and Results: This retrospective cohort study included patients with CHD, aged 0 to 34 years, who underwent surgery between January 2003 and May 2020, followed up at a pediatric subspeciality hospital. Patients were categorized as having simple, moderate, and complex CHD based on 2018 American Heart Association and American College of Cardiology guidelines. Social determinants of health, such as race, ethnicity, language, insurance status, and Child Opportunity Index, based on home address zip code, were analyzed. Of 2012 patients with CHD, a GIC of ≥3 years was identified in 56% (n=1119). The proportion of patients with GIC per year increased by 0.51% ( P <0.001). Multivariable longitudinal models showed that the odds of GIC were higher for patients who were ≥10.5 years old, had simple CHD, lived out of state, lived farther from care site, received public insurance, had less protection with additional insurance plans, and with low Child Opportunity Index. A separate model for patients with only moderate/complex CHD showed similar findings. Race and ethnicity were not associated with the odds of experiencing GIC over time. Conclusions: GIC have increased over time for patients with CHD. Social determinants of health, like insurance, access, and neighborhood opportunity, are key risk factors for increasing GIC. Efforts to reduce GIC in patients with CHD should focus on addressing the impact of specific social determinants of health.


  • Top Cited Papers
    Open Access

    Addressing Disparities in Pediatric Congenital Heart Disease: A Call for Equitable Health Care

    by Devyani Chowdhury, Pietro A. Elliott, S. Yukiko Asaki, Shahnawaz Amdani, Quang‐Tuyen Nguyen, Christina Ronai, Seda Tierney, Victor Y. Levy, Kriti Puri, Carolyn A. Altman, et al.

    While significant progress has been made in reducing disparities within the US health care system, notable gaps remain. This article explores existing disparities within pediatric congenital heart disease care. Congenital heart disease, the most common birth defect and a leading cause of infant death, has garnered substantial attention, revealing certain disparities within the US health care system. Factors such as race, ethnicity, insurance coverage, socioeconomic status, and geographic location are all commonalities that significantly affect health disparities in pediatric congenital heart disease. This comprehensive review sheds light on disparities from diverse perspectives in pediatric care, demonstrates the inequities and inequalities leading to these disparities, presents effective solutions, and issues a call to action for providers, institutions, and the health care system. Recognizing and addressing these disparities is imperative for ensuring equitable care and enhancing the long‐term well‐being of children affected by congenital heart disease. Implementing robust, evidence‐based frameworks that promote responsible and safe interventions is fundamental to enduring change.


  • Open Access

    Mind the Gap! Working Toward Gender Equity in Pediatric and Congenital Heart Disease: Present and Future

    by Devyani Chowdhury, Neha Bansal, Annette Ansong, Carissa Baker Smith, Holly Bauser‐Heaton, Nadine Choueiter, Jennifer Co‐Vu, Pietro Elliott, Stephanie Fuller, Supriya S. Jain, et al.

    Evidence from medicine and other fields has shown that gender diversity results in better decision making and outcomes. The incoming workforce of congenital heart specialists (especially in pediatric cardiology) appears to be more gender balanced, but past studies have shown many inequities. Gender‐associated differences in leadership positions, opportunities presented for academic advancement, and recognition for academic contributions to the field persist. In addition, compensation packages remain disparate if evaluated based on gender with equivalent experience and expertise. This review explores these inequities and has suggested individual and institutional changes that could be made to recruit and retain women, monitor the climate of the institution, and identify and eliminate bias in areas like salary and promotions.


  • Open Access

    Assessment of Value-Based Healthcare Delivery in Cardiac Care for Children of Amish Families

    by Devyani Chowdhury, Mishaal Ather, Corey Snyder, Mallika Kodavatiganti, Fred van Eenennaam, Karla Brigatti, Kevin Strauss

    Background Value-based healthcare is a prominent concept that focuses on patient health outcomes to ensure more efficient healthcare. This patient-centered approach can be applied to establish community-specific personalized care. Unique healthcare solutions need to be developed to adapt to the needs of specific populations. This study highlights the comparison of the delivery of care between the Amish and the Non-Amish community in children who have undergone cardiac surgery. Methods The results are interpreted to reflect areas of the healthcare delivery that lack value. Pediatric Integrated Care Survey (PICS) was sent to parents/guardians of 160 children who had undergone at least one cardiac surgery, and were followed at Cardiology Care for Children. Majority of the self-pay population consisted of the Amish. The survey consisted of 5 components: access, communication, family impact, goal creation and team functioning. Composite score calculation was done to gauge favorable responses. An independent sample t-test was conducted to assess the differences in patient-centered care, with a 95% confidence interval (p Results The self-pay community reported fewer medical comorbidities and had a lower utilization of healthcare than those who were insured. Access to care was equally good in both groups. The self-pay group felt that they had better communication and family impact, whereas the insured group felt that the short and long term goals were better defined. The self-pay and the insured groups valued different components, reflecting different perceptions of healthcare. Conclusion The study suggests the need for innovations in the delivery of cardiac care for children of Amish families. Value and impact of care should be regularly addressed with both the providers and patients. Clear communication between physicians and patients is critical including establishing short and long-term goals. Decision-making should be equal amongst patients and their families. The role of the patients' families should be regularly addressed. Healthcare utilization, cost, and value should be recognized and addressed. Ultimately, a more efficient healthcare delivery system reduces cost for patients and creates high-value care.

  • Open Access

    Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B

    by Katie B. Williams, Michael Horst, Millie Young, Christine Pascua, Erik G. Puffenberger, Karlla W. Brigatti, Claudia Gonzaga-Jauregui, Alan R. Shuldiner, Samuel Gidding, Kevin A. Strauss, et al.

    Familial hypercholesterolemia (FH) due to a founder variant in Apolipoprotein B (ApoBR3500Q) is reported in 12% of the Pennsylvania Amish community. By studying a cohort of ApoBR3500Q heterozygotes and homozygotes, we aimed to characterize the biochemical and cardiac imaging features in children and young adults with a common genetic background and similar lifestyle. We employed advanced lipid profile testing, carotid intima media thickness (CIMT), pulse wave velocity (PWV), and peripheral artery tonometry (PAT) to assess atherosclerosis in a cohort of Amish ApoBR3500Q heterozygotes (n = 13), homozygotes (n = 3), and their unaffected, age-matched siblings (n = 9). ApoBR3500Q homozygotes were not included in statistical comparisons. LDL cholesterol (LDL-C) was significantly elevated among ApoBR3500Q heterozygotes compared to sibling controls, though several ApoBR3500Q heterozygotes had LDL-C levels in the normal range. LDL particles (LDL-P), small, dense LDL particles, and ApoB were also significantly elevated among subjects with ApoBR3500Q. Despite these differences in serum lipids and particles, CIMT and PWV were not significantly different between ApoBR3500Q heterozygotes and controls in age-adjusted analysis. We provide a detailed description of the serum lipids, atherosclerotic plaque burden, vascular stiffness, and endothelial function among children and young adults with FH due to heterozygous ApoBR3500Q. Fasting LDL-C was lower than what is seen with other forms of FH, and even normal in several ApoBR3500Q heterozygotes, emphasizing the importance of cascade genetic testing among related individuals for diagnosis. We found increased number of LDL particles among ApoBR3500Q heterozygotes but an absence of detectable atherosclerosis.


  • Open Access

    Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future

    by Devyani Chowdhury, Jonathan N. Johnson, Carissa M. Baker‐Smith, Robert D. B. Jaquiss, Arjun K. Mahendran, Valerie Curren, Aarti Bhat, Angira Patel, Audrey C. Marshall, Stephanie Fuller, et al.

    The congenital heart care community faces a myriad of public health issues that act as barriers toward optimum patient outcomes. In this article, we attempt to define advocacy and policy initiatives meant to spotlight and potentially address these challenges. Issues are organized into the following 3 key facets of our community: patient population, health care delivery, and workforce. We discuss the social determinants of health and health care disparities that affect patients in the community that require the attention of policy makers. Furthermore, we highlight the many needs of the growing adults with congenital heart disease and those with comorbidities, highlighting concerns regarding the inequities in access to cardiac care and the need for multidisciplinary care. We also recognize the problems of transparency in outcomes reporting and the promising application of telehealth. Finally, we highlight the training of providers, measures of productivity, diversity in the workforce, and the importance of patient–family centered organizations in advocating for patients. Although all of these issues remain relevant to many subspecialties in medicine, this article attempts to illustrate the unique needs of this population and highlight ways in which to work together to address important opportunities for change in the cardiac care community and beyond. This article provides a framework for policy and advocacy efforts for the next decade.


  • Newborn Pulse Oximetry for Infants Born Out-of-Hospital

    by Katie B. Williams, Michael Horst, Erika A. Hollinger, Jacob Freedman, Matthew M. Demczko, Devyani Chowdhury

    BACKGROUND AND OBJECTIVES: Conventional timing of newborn pulse oximetry screening is not ideal for infants born out-of-hospital. We implemented a newborn pulse oximetry screen to align with typical midwifery care and measure its efficacy at detecting critical congenital heart disease.METHODS: Cohort study of expectant mothers and infants mainly from the Amish and Mennonite (Plain) communities with limited prenatal ultrasound use. Newborns were screened at 1 to 4 hours of life (“early screen”) and 24 to 48 hours of life (“late screen”). Newborns were followed up to 6 weeks after delivery to report outcomes. Early screen, late screen, and combined results were analyzed on the basis of strict algorithm interpretation (“algorithm”) and the midwife’s interpretation in the field (“field”) because these did not correspond in all cases.RESULTS: Pulse oximetry screening in 3019 newborns (85% Plain; 50% male; 43% with a prenatal ultrasound) detected critical congenital heart disease in 3 infants. Sensitivity of combined early and late screen was 66.7% (95% confidence interval [CI] 9.4% to 99.2%) for algorithm interpretation and 100% (95% CI 29.2% to 100%) for field interpretation. Positive predictive value was similar for the field interpretation (8.8%; 95% CI 1.9% to 23.7%) and algorithm interpretation (5.4%; 95% CI 0.7% to 18.2%). False-positive rates were ≤1.2% for both algorithm and field interpretations. Other pathologies (noncritical congenital heart disease, pulmonary issues, or infection) were reported in 12 of the false-positive cases.CONCLUSIONS: Newborn pulse oximetry can be adapted to the out-of-hospital setting without compromising sensitivity or prohibitively increasing false-positive rates.